Cavinton tablets

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

vinpocetine

Available from:

Gedeon Richter PLC

ATC code:

N06BX18

INN (International Name):

vinpocetine

Dosage:

5mg

Pharmaceutical form:

tablets

Units in package:

(50/2x25/), in blister

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2015-12-15

Summary of Product characteristics

I,I}ICTPYITIdI,Ifi
tIO
IIPI{MEIMHUIO
JIEKAPCTBEHHOIO
CPEACTBA
AJIX
CIEIIr{A,TLICTOB
1.
T,TAMtrHOBAHI{EMEAl{qrrrrcKoforrpErIApATA
Kas[HToH@,
5
lrr
raO.lerrtu
Karlrxron@
Oopre,
ra6lerxll
2.
KAIIECTBtrI{I{bIIIUKOIUqECTBEHHbIIICOCTAB
Iiaeuwnott
5
'va
nu6ternnt;
KwKAat{
ta6lerxa
c:oAepxir4T
5,0
ur
auHnor{er}rHa-
RctsuumoH
Qopme
mctdtemru,
KDKAa'ra6nerxa
coAepx*rr
r
0,0
ur
BHHnouerHHa.
llo;rx'r
repcqeHb
BcnoMorarerr,rLrx
Beurecrts
[peAcraBneN
a
pa:4ene
6.r.
3.
OAPMATIEBTT4qECKA_tr
OOPMA
Kaouuntou
5
.tta
madtemr.zl.'
6ellte
ltJlrr
roqru
6e,rrre,
rrJrocKne,
Kp)rnble
ra6lerxu
c
r]racrcoi,
6er
san
axa,
c
rpaBr.rpoBr(ofi
'CA
V
INTON*
rra
o;1noii
cropoue
KasururtoLt
6topme
nto1tcntxtt:
l(pyrnble
IrJ'IocKr4e
raO,nerxlt
6eroro
Hnll
rIoqru
6eloro
uBera
c
$acnoir,
c Ha,[nlrcbro
,.10
ntg,
ua
oAHofi
cropoHe
u
plcKofi
Ha
Apyrofi.
Ta6aerxy
MoiKHo
pa3Aennrb
Ha
ABe
paBFIbre
qacrr.r.
4,
KJIIIHITqECKHEOCOEEI{HOCTI4
4.1
TepanerrlruecKuerrona3aH!tfl
Heapotoezn",{'nx
le'teuul
pa3rHt.tHblx
$oprnr
r1epc6poBacKyJupHoi
narorornll:
cocrorHr.{,
noc,le
''epeHece'H0f0
Hapyuerr]rfi
Mo3foBofo
xpoeoo6pauleHrrr
(r.rucylrra),
eepre6po6a:rulpHoI
HeAocraroqHocrlr,
cocylltcroii
Aervreuqrr,'q"p"6p_o"o.o
arepooKnepo3a,
nocTTpaBvaruqecxofi
l,t
runepToH14..recxofi
3Hr{sOaronarnlr.
Crloco6crnyer
yMeHblueHurc
ncaxu'tecxol
H
HeBpoJlofttqecxoi
cLlivinroMarl.rKa
npr
qepe6poeacxylrpnofi
naToJ]0tlil4.
oQtrn*ntnotrc.tetut;
ppa
rerreHur
xpouuuecxofi
cocy4,croii
naroro*rr.r
xopr.rouAer.l
(c
ocy,lncro
i
o
6ono
q
xr.r
r,ra:a)
u
c
erqarrr.r.
ontopuuotapu{ZoJtozLttt;ftr
le'reulrx
crapvecxoii
Tyr'oyxocrlr
nepue[T4BHoro
r]rna,
6o,reeHu
MeHrepa
u
u)4vra
B
yurax.
4.2
,{o:apoexe
lr
cuoco6
npnilrerlclrna
o6-ur'{HbreAo3br
npenaparacocraBrrrcr5-10
nr
3
pa:a
B
cyrKr4
(r5-30
nar
a
c1r.xH).
Ta6,rerxu
ueo6xoAr,rrlro
npuHnr{arb
nocJte
eabl.
[nr
naqleeuroe
c
:a6onesaunrrulr
noliex.q,,rlr.
rteyqgu
gr,r
{!Q'!P{"4,,,9996o
ro
noA6opa
Ao:
rpe6yercr.
flpurueneuue
KaeuHroHa
u,rrur
ki""
y
Aereii
nporrreonoKa3auo
(civr.
pa:4en
4.3).
RenBin000979
I
44t545
ftlnepvyncrnttrerbHocrb
K
ar(T.r4BHor!,ry